| J9271 | Injection, pembrolizumab, 1 mg | 6,600 | $40 | $270.6K |
| J0897 | Injection, denosumab, 1 mg | 3,900 | $20 | $70.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 640 | $100 | $64K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 470 | $70 | $31.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 160 | $150 | $23.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $120 | $19K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 40 | $350 | $14.5K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 10,500 | $1 | $10.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $180 | $7.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 90 | $60 | $5.3K |